Gas Relief

Manufacturer
CVS Pharmacy
Effective date
2020-05-13
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:51:45

Label at a glance#

ProductGas Relief
Active ingredientDIMETHICONE
Label structure10 sections

Dosage and administration

Adults and children 12 years and older; swallow with water 1 or 2 softgels as needed after meals and at bedtime. Do not exceed 2 softgels in 24 hours except under the advice and supervision of a physician

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each softgel)

Simethicone 250mg

Purpose

OTC - PURPOSE SECTION

Anti-gas

Use

INDICATIONS & USAGE SECTION

For the relief of

  • Pressure, bloating or fullness commonly referred to as gas

Warnings

WARNINGS SECTION

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 12 years and older; swallow with water 1 or 2 softgels as needed after meals and at bedtime.
  • Do not exceed 2 softgels in 24 hours except under the advice and supervision of a physician

Other Information

SPL UNCLASSIFIED SECTION

  • store at room temperature 20ºC to 35ºC (68ºF to 77ºF)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

DC Red # 33, FD&C Blue No. 1, Gelatin, Glycerin, purified water, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Call toll-free 1-800-706-5575

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CVS Maximum Strength

Gas Relief

Simethicone 250 mg (anti-gas)

36 Liquid Filled Softgels

Blister Carton label

NDC# 69842-772-03

Simethicone Maximum Strength Softgels are concentrated to contain liquid gas-fighting medicine in a small softgel so they are easy to swallow, and there is no chalky taste.

Carton-labelCarton-label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
412111simethicone 250 MG Oral CapsulePSN2
412111simethicone 250 MG Oral CapsuleSCD2
412111dimethicone 250 MG Oral CapsuleSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DIMETHICONE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69842-772-032024-01-30C16284748780-11030e365-540c-111a-e063-dadaa90a10e2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69842-772-03Gas Relief12 in 1 BLISTER PACKCAPSULE, GELATIN COATED122
69842-772-03Gas Relief3 in 1 CARTONCAPSULE, GELATIN COATED32

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69842-772GAS RELIEF (SIMETHICONE) CAPSULE, GELATIN COATED [CVS PHARMACY]2Legacy NDC, 2 package rows20221123_0d8fe3d5-1e5e-152e-98e0-bc9cea139ba6.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-77269842-772-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
274923dd-8589-6c7b-9083-1daba49274850d8fe3d5-1e5e-152e-98e0-bc9cea139ba62020-05-13WarningsExact identifier
spl id: 274923dd-8589-6c7b-9083-1daba4927485
spl set id: 0d8fe3d5-1e5e-152e-98e0-bc9cea139ba6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.